About SwimCount™
About MotilityCount ApS – The company behind the SwimCount™ brand
MotilityCount ApS was founded in 2011 by entrepreneurs and scientists with many years of experience in Assisted Reproductive Technology (ART). MotilityCount has developed the SwimCount™ Sperm Quality Test – an at-home test for the early diagnosis of male fertility, SwimCount™ Sperm Care – a dietary supplement, and the SwimCount™ Harvester – an innovative microfluidic purification method that can improve treatment outcomes in IUI, IVF, and ICSI. Additionally, MotilityCount is behind the VetCount™ Harvester and the PetCount™ Sperm Quality Test.
MotilityCount is funded by private investors, the Danish foundation Welfare Tech Invest as well as the Export and Investment Fund of Denmark (EIFO).
2014 - Patent Granted
The patent for the SwimCount™ Membrane Swim-Up Techlology is granted.
2015 - CE IVD Approval
MotilityCount ApS obtains the European Union CE Regulatory Approval for the SwimCount™ Sperm Quality Test.
2019 - US FDA 510(k) Clearance
MotilityCount ApS obtains the US FDA 510(k) clearance for the SwimCount™ Sperm Quality Test.
2020 - ISO 13485:2016 & EN ISO 13485:2016
MotilityCount ApS obtains the ISO13485:2016 certificate.
2020 - Eurostars
MotilityCount ApS obtains a huge grant and takes part i an European Funding Program: Eurostars.
2022 - Upgraded to an IVDR CE Approval
The CE Regulatory Approval for the SwimCount™ Sperm Quality Test is upgraded to an IVDR CE regulatory Approval.
2024 - CE MDR Regulatory Approval
MotilityCount ApS obtains the CE MDR Regulatory Approval for the SwimCount™ Harvester.
2025 - US FDA 510(k) Clearance
MotilityCount ApS obtains the US FDA 510(k) Clearance for the SwimCount® Harvester.